Fusion Antibodies (LON:FAB) Stock Price Down 12.7% – Time to Sell?

Fusion Antibodies plc (LON:FAB) was down 12.7% during mid-day trading on Thursday . The stock traded as low as GBX 7.68 ($0.09) and last traded at GBX 7.68 ($0.09). Approximately 1,231,095 shares changed hands during trading, a decline of 54% from the average daily volume of 2,684,324 shares. The stock had previously closed at GBX 8.80 ($0.11).

Fusion Antibodies Trading Up 6.3 %

The firm has a market cap of £8.11 million, a price-to-earnings ratio of -212.50 and a beta of 0.49. The company has a debt-to-equity ratio of 2.40, a quick ratio of 2.36 and a current ratio of 3.87. The business has a fifty day moving average of GBX 6.43 and a two-hundred day moving average of GBX 4.58.

About Fusion Antibodies

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.